Visceral leishmaniasis treated with liposomal amphotericin B

Pediatr Infect Dis J. 1999 Jan;18(1):73-4. doi: 10.1097/00006454-199901000-00021.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Amphotericin B / administration & dosage*
  • Antiprotozoal Agents / administration & dosage*
  • Child, Preschool
  • Humans
  • Infant
  • Italy / epidemiology
  • Leishmaniasis, Visceral / drug therapy*
  • Leishmaniasis, Visceral / epidemiology
  • Liposomes
  • Male

Substances

  • Antiprotozoal Agents
  • Liposomes
  • Amphotericin B